CALM Human

Calmodulin Human
Shipped with Ice Packs
In Stock

Description

Biochemical Properties of CALM

CALM is a 70 kDa protein encoded by the PICALM gene. Structurally, it contains:

  • ANTH domain (AP180 N-terminal homology): Binds phosphatidylinositol-4,5-bisphosphate (PIP2) on membranes .

  • Assembly Domain (AD): Includes a clathrin-binding CLAP motif and motifs for adapter protein interactions .

  • Nuclear Export Signal (NES): Facilitates nucleocytoplasmic shuttling .

Post-translational modifications include phosphorylation and O-GlcNAc modifications, which regulate its activity .

Functional Roles in Clathrin-Mediated Endocytosis

CALM orchestrates clathrin-coated vesicle formation by:

  • Recruiting clathrin triskelia via its CLAP domain .

  • Binding to adapter proteins (e.g., AP2) to stabilize vesicle assembly .

  • Facilitating cargo sorting, including receptors like transferrin and low-density lipoprotein .

3.1. Leukemia

CALM fusion proteins (e.g., CALM-AF10) are drivers of acute myeloid leukemia (AML). These oncogenic fusions disrupt transcriptional regulation, leading to uncontrolled myeloid cell proliferation .

3.2. Alzheimer’s Disease (AD)

CALM is implicated in AD through four hypothesized mechanisms :

  1. Aβ Clearance: Modulates LRP1-mediated transcytosis of Aβ peptides across the blood-brain barrier.

  2. Microglial Dysfunction: Altered CALM expression in microglia impairs immune signaling.

  3. Tau Pathology: CALM fragments co-localize with hyperphosphorylated tau in neurofibrillary tangles.

  4. APP Processing: Influences amyloid precursor protein (APP) trafficking, affecting Aβ production.

Therapeutic and Research Implications

  • Cancer: Targeting CALM-AF10 interactions could inhibit leukemia progression .

  • Neurodegeneration: CALM’s role in Aβ and tau metabolism highlights its potential as a biomarker or therapeutic target .

Key Research Findings

  • CALM depletion in HeLa cells causes multinucleation and delayed cytokinesis, underscoring its role in cell division .

  • In AD models, reduced CALM expression correlates with decreased Aβ plaques but worsened tau pathology .

Product Specs

Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
CALM was lyophilized with 2mM EDTA.
Stability
Lyophilized CALM is stable at room temperature for 3 weeks but should be stored desiccated below -18°C. Upon reconstitution, Calmodulin should be stored at 4°C for 2-7 days and below -18°C for future use. For long-term storage, adding a carrier protein (0.1% HSA or BSA) is recommended. Avoid freeze-thaw cycles.
Solubility
Reconstitute the lyophilized CALM in sterile 18MΩ-cm H2O at a concentration of at least 100µg/ml. This solution can be further diluted with other aqueous solutions.
Purity
Greater than 95.0%.
Applications
This product was sourced from tissue donors tested negative for syphilis, HBsAg, HIV-1 and HIV-2 antibodies, and HCV.
Synonyms

Calmodulin, CaM, CALM.

Source

Human brain tissue.

Q&A

What is CALM in the context of human research and what are its foundational principles?

CALM is an evidence-based program designed to provide space and time to support educators' daily wellbeing through mindfulness practices. Unlike retreat-based models, CALM is founded on a place-based daily practice model that integrates into school communities .

The foundational principles of CALM are built on a logic model that hypothesizes regular participation in four key activities:

  • Mindful awareness of present moment experiences

  • Breathing exercises

  • Gentle movement practices

  • Intention setting

These activities are theorized to strengthen three primary psychological capacities:

  • Emotion regulation

  • Attention control

  • Stress management abilities

How does research on natural calming compounds relate to CALM-based mindfulness studies?

While distinct in methodology, both CALM mindfulness research and studies on natural calming compounds converge in their focus on psychological wellbeing and stress reduction. Recent clinical research demonstrates that phospholipid carrier-based Melissa officinalis L. (lemon balm) extract possesses considerable neuropharmacological properties for managing emotional distress and sleep conditions .

The primary active constituents include:

  • Antioxidant polyphenols (rosmarinic acid >5%)

  • Flavonoids (luteolin-3′-O-glucuronide)

  • Terpenes (citronellal, neral, and geranial)

These compounds may influence similar neurological pathways to those affected by mindfulness practices. Both approaches potentially modulate overlapping neurophysiological systems, including:

  • Stress hormone regulation

  • Oxytocin release pathways

  • Autonomic nervous system functioning

This suggests valuable opportunities for integrated research approaches examining complementary mechanisms of calmness induction .

What is the relationship between oxytocin and calming effects in human research?

Oxytocin has emerged as a critical neurohormone that simultaneously upregulates wellbeing and downregulates stress and anxiety. This 9-amino acid peptide, synthesized in the supraoptic nucleus and paraventricular nucleus of the hypothalamus, is released into both bloodstream and brain in response to specific stimuli .

Research indicates that when the paraventricular nucleus is activated, oxytocin levels increase, creating what researchers describe as a "well-being circuit." This appears to operate as a positive feedback system, though the precise mechanisms remain under investigation .

In the central nervous system, oxytocin modulates neural circuits involved in:

  • Stress response regulation

  • Anxiety reduction

  • Sensory processing enhancement

  • Social bonding facilitation

This suggests that oxytocin may be a key neurobiological mediator underlying both mindfulness-based interventions like CALM and the effects of natural calming compounds .

What populations have been studied using CALM interventions and what were the key findings?

CALM has been implemented and studied primarily in educational settings across multiple states including Pennsylvania, Delaware, Ohio, and Kentucky. The principal research populations include:

PopulationStudy LocationSample SizeImplementation Details
K-12 EducatorsPennsylvania middle schools64 educators (42 teachers, 22 paraprofessionals)Intervention school (n=34), Control school (n=30)
TeachersCleveland Metro SchoolsNot specifiedPart of district initiative
School staffRed Clay Schools, DelawareNot specifiedDistrict-wide implementation
EducatorsJefferson County, KY25 schoolsPart of Compassionate Schools Project

The initial research at Pennsylvania middle schools employed a waiting-list control design to evaluate CALM's effectiveness. While the search results don't specify detailed outcome measures, the research focused on CALM's impact on educator wellbeing, stress reduction, and professional functioning .

Over 40 instructors have been trained to facilitate CALM in schools, indicating significant scaling of the intervention beyond initial research sites .

What theoretical models explain the effectiveness of calming interventions in humans?

Two complementary theoretical models help explain the effectiveness of calming interventions:

1. The CALM Logic Model:
This framework specifies that daily mindfulness practices lead to strengthened psychological capacities (emotion regulation, attention, stress management), which in turn improve wellbeing outcomes, physiological functioning, professional effectiveness, and workplace climate .

2. The Hypothalamic-Pituitary-Adrenal (HPA) Axis-Oxytocin Model:
This neurobiological model explains how mindfulness practices influence stress physiology. When the paraventricular nucleus is activated through certain practices, oxytocin levels increase, creating a "well-being circuit" that modulates stress responses controlled by the HPA axis .

This model explains why diverse interventions including mindfulness meditation, placebo effects, and even sensory experiences like fragrance can reduce stress and anxiety, resulting in states of contentment. The model provides a neurobiological framework that bridges psychological experiences with underlying physiological mechanisms .

What methodological challenges arise in designing controlled studies of CALM interventions?

Researchers face several methodological challenges when designing rigorous studies of CALM and similar interventions:

Sample Selection and Randomization:
True randomization is often challenging in educational settings where intact groups (schools/departments) typically participate together. The CALM research addressed this by using volunteer schools randomized to intervention or waiting-list control conditions .

Intervention Standardization:
Maintaining intervention fidelity while allowing for contextual adaptation presents a significant challenge. CALM addresses this through manualization with weekly thematic focuses and structured variations in four daily sessions .

Appropriate Control Conditions:
Selecting controls that account for non-specific factors (attention, expectation, social support) without containing active ingredients requires careful design consideration. Waiting-list controls, while practical, don't control for all non-specific factors.

Measurement Timing:
Determining optimal assessment points to capture both immediate effects and sustained changes requires longitudinal designs that may be logistically challenging in educational settings.

Ecological Validity vs. Experimental Control:
Balancing real-world implementation (ecological validity) with sufficient experimental control represents an ongoing tension in CALM research design.

These challenges require innovative methodological approaches that maintain scientific rigor while acknowledging the complex, real-world contexts in which CALM is implemented.

How do researchers differentiate direct neurophysiological effects from placebo responses in calmness studies?

Differentiating direct neurophysiological effects from placebo responses in calmness research requires sophisticated methodological approaches:

Integration of Objective Biomarkers:
Measuring physiological parameters such as oxytocin levels, stress hormone concentrations, or neuroimaging data provides objective correlates that extend beyond subjective reports .

Mechanistic Analysis:
Research suggests that placebo effects themselves operate through defined neurobiological pathways, potentially involving oxytocin's influence on the HPA axis. Understanding these mechanisms helps researchers recognize that placebo responses represent real neurophysiological phenomena rather than simply experimental confounds .

Double-Blinded Designs:
For studies of natural compounds with calming effects, double-blinded, placebo-controlled designs are essential. The research on phospholipid carrier-based Melissa officinalis extract employed this approach to isolate specific effects from placebo responses .

Dose-Response Relationships:
Establishing clear relationships between intervention intensity (frequency/duration) and outcomes provides evidence for direct effects that typically exceed what would be expected from placebo alone.

Alternative Control Conditions:
Using active control conditions that match the intervention in expectancy and engagement but lack theorized active components helps isolate specific effects from non-specific factors.

These approaches collectively help researchers distinguish between direct neurophysiological effects and placebo responses while acknowledging their interactive nature in promoting calmness.

What physiological mechanisms potentially explain the synergistic effects of combined calming interventions?

Research suggests several physiological mechanisms that may explain synergistic effects when combining different calming approaches (e.g., mindfulness practices and natural compounds):

Oxytocin Pathway Modulation:
Both mindfulness practices and certain natural compounds may influence oxytocin production and release through complementary mechanisms. The paraventricular nucleus activation appears central to this process, potentially creating a "well-being circuit" that can be stimulated through multiple pathways simultaneously .

HPA Axis Regulation:
The HPA axis-oxytocin model proposes that interventions can reduce stress by modulating this key physiological system. Combined approaches may affect different components of this system (hypothalamic, pituitary, and adrenal functions) for enhanced regulation .

Neurotransmitter Balance:
Natural compounds like those in Melissa officinalis contain constituents that may influence GABAergic and serotonergic systems, potentially complementing the neurotransmitter effects of mindfulness practices .

Inflammatory Pathway Influence:
Chronic stress increases inflammatory markers, while both mindfulness practices and certain natural compounds demonstrate anti-inflammatory properties. Combined interventions may more effectively reduce systemic inflammation.

Autonomic Nervous System Regulation:
Parasympathetic activation ("rest and digest" response) appears to be a common pathway through which various calming interventions operate, suggesting potential for synergistic effects when combining approaches.

These mechanisms provide theoretical foundations for investigating combined interventions, though more research is needed to fully understand their interactive effects.

How do researchers control for individual variability in response to CALM interventions?

Individual variability presents significant challenges in CALM research, requiring several methodological strategies:

Baseline Characterization:
Comprehensive assessment of relevant baseline characteristics helps identify potential moderators of intervention response. Important variables include:

  • Prior meditation experience

  • Baseline stress levels

  • Personality factors

  • Genetic polymorphisms related to stress response

  • Sleep quality

Statistical Approaches:
Advanced statistical methods help account for individual variability:

  • Mixed effects modeling to nest observations within individuals

  • Growth curve analyses to examine individual trajectories

  • Latent class analyses to identify response patterns

  • Bayesian approaches to model individual differences

Moderator Analyses:
Systematic examination of how participant characteristics interact with intervention effects helps identify for whom CALM works best and under what conditions.

Idiographic Assessment:
Person-specific analyses complement group-level findings by examining individual response patterns, particularly valuable given the heterogeneity in stress responses.

Crossover Designs:
When feasible, having participants serve as their own controls through crossover designs helps control for individual differences while increasing statistical power.

These approaches collectively strengthen researchers' ability to account for and understand individual variability in response to CALM interventions.

What novel assessment technologies are advancing measurement precision in calmness research?

Several emerging technologies are enhancing measurement precision in calmness research:

Wearable Physiological Monitors:
Continuous monitoring of heart rate variability, electrodermal activity, and sleep patterns provides ecologically valid data on autonomic nervous system functioning associated with calmness states.

Portable EEG Systems:
Increasingly accessible electroencephalography technology enables assessment of neural oscillatory patterns (particularly alpha and theta waves) associated with meditative states and relaxation.

Salivary Bioscience:
Advanced salivary assays allow non-invasive assessment of multiple biomarkers including:

  • Cortisol (stress hormone)

  • Alpha-amylase (sympathetic nervous system activity)

  • Immunoglobulins (immune system functioning)

  • Potentially oxytocin levels

Ecological Momentary Assessment (EMA) Platforms:
Smartphone-based EMA enables repeated sampling of subjective experiences in natural environments, reducing recall bias and capturing dynamic fluctuations in calmness states.

Virtual Reality Systems:
VR technology provides standardized environmental stimuli for assessing stress reactivity and calmness induction while maintaining experimental control.

Machine Learning Approaches:
Advanced algorithms applied to multimodal data streams can identify subtle patterns and relationships not detectable through traditional statistical methods.

These technologies offer unprecedented opportunities for capturing both the subjective experience and physiological manifestations of calmness with greater precision, temporal resolution, and ecological validity than previously possible.

How might findings from oxytocin research inform the development of enhanced CALM protocols?

Oxytocin research offers several insights that could enhance CALM protocols:

Targeted Component Design:
Understanding oxytocin's role in wellbeing suggests CALM protocols could be enhanced by specifically incorporating elements that stimulate oxytocin release :

  • Social connection exercises

  • Compassion-focused meditation practices

  • Sensory awareness components

  • Touch-based activities (where appropriate)

Biomarker-Guided Optimization:
Oxytocin levels could potentially serve as a biomarker for evaluating and refining CALM protocols, allowing researchers to correlate subjective experiences with physiological changes .

Personalized Protocol Development:
Research on individual differences in oxytocin system functioning could inform personalized approaches to CALM implementation, tailoring practices to individual neurophysiological profiles.

Timing Considerations:
Understanding oxytocin's temporal dynamics could help determine optimal scheduling for CALM practices to maximize neurophysiological benefits.

Integration with Complementary Approaches:
Knowledge of how oxytocin interacts with other neurobiological systems could inform the integration of CALM with complementary approaches like natural compounds that influence related pathways .

Incorporating these insights from oxytocin research could lead to more targeted, effective, and personalized CALM protocols with enhanced benefits for participants.

What statistical approaches best capture the multidimensional nature of calmness responses?

The multidimensional nature of calmness requires sophisticated statistical approaches:

Structural Equation Modeling (SEM):
SEM allows researchers to test complex theoretical models of how CALM influences multiple outcome domains through various mediating mechanisms, capturing both direct and indirect pathways of effect.

Multilevel Modeling:
This approach accounts for nested data structures (observations within individuals, individuals within groups) while examining effects across multiple levels of analysis.

Network Analysis:
Rather than treating symptoms as manifestations of latent constructs, network approaches model symptoms as interactive networks, valuable for understanding how different aspects of calmness interact.

Latent Profile Analysis:
This person-centered approach identifies subgroups with distinct patterns of response across multiple outcome dimensions, capturing heterogeneity in how individuals experience calmness.

Time Series Analysis:
For intensive longitudinal data, time series approaches capture temporal dynamics and patterns in calmness states over time and across contexts.

Bayesian Methods:
Bayesian approaches incorporate prior knowledge and handle complex models with multiple parameters, particularly valuable when examining multidimensional outcomes with limited sample sizes.

These advanced statistical approaches help researchers move beyond simplistic analyses to capture the complex, multidimensional nature of how CALM and related interventions influence human wellbeing.

How do researchers effectively translate CALM research findings into sustainable implementation models?

Translating CALM research into sustainable implementation models requires addressing several key considerations:

Implementation Science Frameworks:
Utilizing established frameworks like RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) helps researchers systematically address factors affecting successful translation.

Stakeholder Engagement:
Early and ongoing engagement with key stakeholders (educators, administrators, policymakers) ensures implementation approaches address real-world constraints and opportunities.

Implementation PhaseKey StakeholdersEngagement Methods
PlanningAdministrators, teacher representativesFocus groups, advisory committees
AdaptationFrontline educators, wellness coordinatorsCollaborative design sessions
ImplementationTrained facilitators, participantsOngoing feedback loops
SustainabilityDistrict leadership, policy makersData sharing, policy integration

Intervention Adaptation:
Systematic approaches to adapting CALM while maintaining core components ensures contextual fit without sacrificing effectiveness.

Training Infrastructure:
Developing scalable training models (like the 40+ instructors trained to facilitate CALM in schools) creates capacity for sustainable implementation .

Integration with Existing Systems:
Embedding CALM within existing organizational structures and workflows increases likelihood of sustainability rather than treating it as an "add-on" program.

Continuous Quality Improvement:
Establishing ongoing monitoring and feedback mechanisms ensures implementation quality remains high while allowing for continuous refinement.

These approaches help bridge the research-to-practice gap, ensuring that promising findings from CALM studies translate into sustainable implementations with real-world impact.

What methodological approaches best capture both immediate and longitudinal effects of CALM interventions?

Capturing both immediate and longitudinal effects requires thoughtful methodological approaches:

Measurement Timing Strategy:
Strategic timing of assessments to capture:

  • Baseline functioning (pre-intervention)

  • Immediate effects (during/immediately post-intervention)

  • Short-term maintenance (1-3 months post-intervention)

  • Long-term sustainability (6+ months post-intervention)

  • Potential sleeper effects (benefits that emerge over time)

Mixed-Methods Sequential Design:
Integrating quantitative and qualitative approaches in sequence:

  • Quantitative assessments capture measurable changes across time points

  • Qualitative interviews explore lived experience and mechanisms of change

  • Integration of findings provides comprehensive understanding of effects

Intensive Longitudinal Methods:
Daily diary or ecological momentary assessment approaches capture more granular temporal dynamics than traditional pre-post designs.

Trajectory Modeling:
Statistical approaches like growth curve modeling or latent change score models examine individual trajectories over time rather than simple pre-post comparisons.

Follow-up Protocols:
Carefully designed follow-up strategies maintain contact with participants to minimize attrition in longitudinal studies.

Biomarker Archives:
Collection and storage of biological samples allows for later analysis as new assay technologies develop.

These approaches enable researchers to document not only whether CALM interventions work, but how effects unfold over time and what factors influence their sustainability.

How can researchers integrate neurobiological and psychological models in CALM research?

Integrating neurobiological and psychological models requires several methodological approaches:

Multi-level Measurement:
Simultaneous assessment across levels of analysis:

  • Molecular (e.g., oxytocin, cortisol)

  • Neural (e.g., functional connectivity)

  • Physiological (e.g., autonomic nervous system)

  • Psychological (e.g., emotion regulation)

  • Behavioral (e.g., stress management)

  • Social (e.g., workplace relationships)

Theoretical Integration:
Explicit connection between the CALM Logic Model and the HPA axis-oxytocin model to create an integrated theoretical framework that spans psychological processes and neurobiological mechanisms.

Mediation Analysis:
Statistical examination of whether neurobiological changes (e.g., oxytocin levels, HPA axis function) mediate the relationship between CALM participation and psychological outcomes.

Interdisciplinary Collaboration:
Research teams that include experts in both psychological interventions and neurobiological mechanisms ensure integration at the study design level.

Model Testing:
Development and testing of formal computational models that mathematically specify relationships between neurobiological and psychological variables.

Translational Approaches:
Bidirectional translation between animal models (providing mechanistic precision) and human studies (providing ecological validity) strengthens integrated understanding.

These approaches help bridge traditionally separate research traditions, creating more comprehensive models of how CALM interventions influence human wellbeing across multiple levels of analysis.

Product Science Overview

Structure

Calmodulin is a small protein composed of 148 amino acids, with a molecular weight of approximately 16.7 kDa . It has two symmetrical globular domains (N- and C-domains), each containing a pair of EF-hand motifs, which are helix-loop-helix structures that bind calcium ions . These domains are connected by a flexible central linker, allowing calmodulin to bind a total of four Ca²⁺ ions . The binding of calcium induces a conformational change in calmodulin, enabling it to interact with various target proteins .

Function

Calmodulin mediates a wide range of cellular processes, including:

  • Inflammation
  • Metabolism
  • Apoptosis (programmed cell death)
  • Smooth muscle contraction
  • Intracellular movement
  • Short-term and long-term memory
  • Immune response

When calcium binds to calmodulin, it forms a Ca²⁺/calmodulin complex that can interact with and regulate numerous enzymes, ion channels, and other proteins . For example, the Ca²⁺/calmodulin complex can activate calcium pumps that remove calcium from the cytoplasm, thereby regulating downstream cellular responses .

Genetic Encoding

In humans, calmodulin is encoded by three genes: CALM1, CALM2, and CALM3, located on chromosomes 14, 2, and 19, respectively . These genes ensure the production of calmodulin in various tissues and under different physiological conditions.

Importance of Flexibility

Calmodulin’s ability to recognize and bind to a diverse range of target proteins is largely due to its structural flexibility . The flexible central linker and the open-closed conformational cycling of the N- and C-domains in the Ca²⁺-bound state allow calmodulin to adapt to different target proteins . This flexibility, combined with the predominantly hydrophobic nature of its binding interactions, enables calmodulin to recognize approximately 300 different target proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.